OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study
Sławomir Murawiec, Marek Krzystanek
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 526-526
Open Access | Times Cited: 6
Sławomir Murawiec, Marek Krzystanek
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 526-526
Open Access | Times Cited: 6
Showing 6 citing articles:
Moving from serotonin to serotonin-norepinephrine enhancement with increasing venlafaxine dose: clinical implications and strategies for a successful outcome in major depressive disorder
Andrea Fagiolini, Narcı́s Cardoner, Şebnem Pırıldar, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1715-1723
Open Access | Times Cited: 11
Andrea Fagiolini, Narcı́s Cardoner, Şebnem Pırıldar, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 15, pp. 1715-1723
Open Access | Times Cited: 11
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort
Pasquale Paribello, Mirko Manchia, Marco Pinna, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 3
Closed Access
Pasquale Paribello, Mirko Manchia, Marco Pinna, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 3
Closed Access
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
Marek Krzystanek, Anna Warchała, Beata Trędzbor, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 947-947
Open Access | Times Cited: 4
Marek Krzystanek, Anna Warchała, Beata Trędzbor, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 947-947
Open Access | Times Cited: 4
The Profile of Symptom Change with Transcranial Magnetic Stimulation for Major Depressive Disorder
Todd Hutton, Scott T. Aaronson, Linda L. Carpenter, et al.
Transcranial magnetic stimulation . (2024) Vol. 1, pp. 100074-100074
Open Access
Todd Hutton, Scott T. Aaronson, Linda L. Carpenter, et al.
Transcranial magnetic stimulation . (2024) Vol. 1, pp. 100074-100074
Open Access
When drug-centred psychopharmacology meets person-centred psychopharmacotherapy – antidepressants
Sławomir Murawiec
Psychiatria i Psychologia Kliniczna (2023) Vol. 22, Iss. 4, pp. 204-213
Open Access | Times Cited: 1
Sławomir Murawiec
Psychiatria i Psychologia Kliniczna (2023) Vol. 22, Iss. 4, pp. 204-213
Open Access | Times Cited: 1
Personalized psychopharmacology in integrated medical model
Marek Krzystanek, I. Krupka-Matuszczyk, Beata Trędzbor, et al.
Psychiatria Spersonalizowana (2023) Vol. 2, Iss. 1, pp. 1-6
Open Access
Marek Krzystanek, I. Krupka-Matuszczyk, Beata Trędzbor, et al.
Psychiatria Spersonalizowana (2023) Vol. 2, Iss. 1, pp. 1-6
Open Access
Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?
Sławomir Murawiec, Natalia Olejnik, Agata Kudlik
Psychiatria Spersonalizowana (2023) Vol. 2, Iss. 1, pp. 7-15
Open Access
Sławomir Murawiec, Natalia Olejnik, Agata Kudlik
Psychiatria Spersonalizowana (2023) Vol. 2, Iss. 1, pp. 7-15
Open Access
